ESC Premium Access

Welcome and introduction - Clinical considerations for cardiologists: exploring the evidence for primary and secondary prevention in type 2 diabetes.

Congress Presentation

About the speakers

Professor Gaetano Maria De Ferrari

Hospital Molinette of the University Hospital S. Giovanni Battista, Turin (Italy)
18 presentations
0 follower

Professor Lawrence Leiter

University of Toronto, Toronto (Canada)
19 presentations
0 follower

6 more presentations in this session

Coprevalence of comorbidities and their role in the choices of treatment for the diabetic patient with cardiovascular disease.

Speaker: Professor N. Marx (Aachen, DE)

Thumbnail

Newly emerging data from the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) cardiovascular safety trial: an investigator’s perspective.

Speaker: Doctor P. Armstrong (Edmonton, CA)

Thumbnail

Diabetes cardiovascular safety trials: an endocrinologist’s interpretation of emergent data.

Speaker: Professor L. Leiter (Toronto, CA)

Thumbnail

Closing the gap: the EUROASPIRE study (European Action on Secondary Prevention by Intervention to Reduce Events) and what it can tell us for the treatment of diabetes patients.

Speaker: Professor L. Ryden (Stockholm, SE)

Thumbnail

Q&A - Clinical considerations for cardiologists: exploring the evidence for primary and secondary prevention in type 2 diabetes.

Speaker: Professor N. Marx (Aachen, DE) Doctor P. Armstrong (Edmonton, CA) Professor L. Ryden (Stockholm, SE) Professor L. Leiter (Toronto, CA)

Thumbnail

Access the full session

Clinical considerations for cardiologists: exploring the evidence for primary and secondary prevention in type 2 diabetes

Speakers: Professor G. De Ferrari, Professor L. Leiter, Professor N. Marx, Doctor P. Armstrong, Professor L. Leiter...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb